Commonwealth Equity Services’s Evoke Pharma EVOK Stock Holding History

Commonwealth Equity Services’s Portfolio EVOK Stock Details EVOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-209	Closed	-$77K	–	3420
2020 Q4	$77K	Sell	209 -16	-7%	-$8.25K	﹤0.01%	3095
2020 Q3	$151K	Hold	225	–	–	﹤0.01%	2804
2020 Q2	$114K	Hold	225	–	–	﹤0.01%	2752
2020 Q1	$37K	Hold	225	–	–	﹤0.01%	2709
2019 Q4	$52K	Hold	225	–	–	﹤0.01%	2797
2019 Q3	$27K	Hold	225	–	–	﹤0.01%	2784
2019 Q2	$20K	Hold	225	–	–	﹤0.01%	2742
2019 Q1	$48K	Hold	225	–	–	﹤0.01%	2662
2018 Q4	$80K	Hold	225	–	–	﹤0.01%	2525
2018 Q3	$96K	Sell	225 -62	-22%	-$24.7K	﹤0.01%	2643
2018 Q2	$103K	Buy	287 +62	+28%	+$23.2K	﹤0.01%	2603
2018 Q1	$67K	Hold	225	–	–	﹤0.01%	2580
2017 Q4	$73K	Buy	225 +16	+8%	+$6.63K	﹤0.01%	2538
2017 Q3	$100K	Hold	209	–	–	﹤0.01%	2414
2017 Q2	$77K	Hold	209	–	–	﹤0.01%	2394
2017 Q1	$93K	Hold	209	–	–	﹤0.01%	2291
2016 Q4	$61K	Buy	209 +125	+149%	+$32.4K	﹤0.01%	2233
2016 Q3	$27K	Buy	+84	New	+$38.4K	﹤0.01%	2198

Other funds holding EVOK

ACM

AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

WVP

Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Wambolt & Associates Littleton, Colorado $297M AUM 17.23% 1-Year Est. Return

Commonwealth Equity Services's EVOK Position: Q1 2021 in Review

Commonwealth Equity Services sold out of Evoke Pharma (EVOK) in Q1 2021, closing a stake of 209 shares — an estimated $77K sold.

Commonwealth Equity Services first reported a position in EVOK in Q3 2016 and held it in 18 quarters. The position peaked at $151K in Q3 2020. 25 funds tracked by Wall St. Rank hold EVOK as of Q1 2021.

Commonwealth Equity Services reported no remaining Evoke Pharma position as of Q1 2021 after selling out during the quarter.
Commonwealth Equity Services sold 209 Evoke Pharma shares in Q1 2021, an estimated $77K.
Commonwealth Equity Services first reported a position in Evoke Pharma in Q3 2016 and held it in 18 quarters.
Commonwealth Equity Services's Evoke Pharma position peaked at $151K in Q3 2020.
25 funds tracked by Wall St. Rank held Evoke Pharma as of Q1 2021.

Based on Commonwealth Equity Services's 13F filing for Q1 2021, filed 4 May 2021.